Medicare billing address
CMS Medicare provider billing file
2121 N 1700 WLayton, UT 84041
CMS public data · NPI 1881013951
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Ryan N Hoggan, M.D.
Specialty
Credential
M.D.
NPI
1881013951
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Ryan N Hoggan, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2121 N 1700 WCMS Doctors & Clinicians file
2121 N 1700In the 2024 CMS provider billing file, this NPI had 148 Medicare beneficiaries and 21,935 total services. The average beneficiary age was 71, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$407,852.49
Total Medicare payment amount
$325,584.64
Medicare beneficiaries
148
Total services
21,935
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
68%
CMS beneficiary-panel share
Hyperlipidemia
54%
CMS beneficiary-panel share
Chronic kidney disease
38%
CMS beneficiary-panel share
Mood disorders
37%
CMS beneficiary-panel share
Depression
36%
CMS beneficiary-panel share
Diabetes
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Measurement of antibody for assessment of autoimmune disorder, any method | 278 | $17.57 |
| Insertion of needle into vein for collection of blood sample | 242 | $8.61 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 220 | $2.64 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 219 | $12.69 |
| Blood test, comprehensive group of blood chemicals | 202 | $10.31 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 199 | $7.58 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 132 | $85.68 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 81 | $121.76 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 71 | $57.78 |
| Administration of chemotherapy into vein, each additional hour | 65 | $25.71 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1881013951. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 290 | 671 | $14,126.49 |
| 2 | Methotrexate | Methotrexate Sodium | 205 | 451 | $5,825.41 |
| 3 | Prednisone | Prednisone | 108 | 123.9 | $648.10 |
| 4 | Leucovorin Calcium | Leucovorin Calcium | 75 | 131.2 | $708.25 |
| 5 | Enbrel Sureclick | Etanercept | 72 | 72 | $558,375.79 |
| 6 | Sulfasalazine Dr | Sulfasalazine | 70 | 128 | $3,369.88 |
| 7 | Sulfasalazine | Sulfasalazine | 66 | 146 | $1,927.55 |
| 8 | Celecoxib | Celecoxib | 65 | 153.3 | $1,712.13 |
| 9 | Folic Acid | Folic Acid | 65 | 184.3 | $1,069.24 |
| 10 | Azathioprine | Azathioprine | 47 | 106.7 | $1,155.75 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Utah School Of Medicine
Graduation year
2014
Group/practice field
Tanner Memorial Clinic
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.